Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Selpercatinib is a highly selective RET inhibitor that inhibits the growth of tumor cells by blocking RET kinase activity. In May 2020, the FDA approved the drug for use as an impo···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：216
Selpercatinib is the first targeted drug specifically targeting RET gene mutations and was approved by the FDA in 2020; By inhibiting the activity of RET kinase and blocking the gr···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：184
In May 2020, Selpercatinib was approved by the FDA for the treatment of various cancers caused by RET gene mutations. The drug stops the spread of the lesion by interfering with th···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：254
Selpercatinib treats cancer patients by specifically inhibiting RET kinase activity. In 2020, it was approved for marketing in United States, becoming the first drug specifically t···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：208
Selpercatinib helps control the proliferation and metastasis of cancer cells by blocking the RET signaling pathway. The drug, which is indicated for patients over 12 years of age, ···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：290
As a highly selective RET inhibitor, Selpercatinib is used for the treatment of RET fusion-positive and mutation-associated cancers. It was approved by the FDA in 2020 and has show···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：225
The commonly used dosage form of Mitotane is a tablet, which is an antineoplastic drug. It is used to treat inoperable adrenocortical tumors. Cushing syndrome can also be treated.W···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：205
Selpercatinib is a targeted drug that specifically targets mutations in the RET gene. By inhibiting RET kinase activity, it prevents the growth and spread of cancer cells. It is su···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：215
By inhibiting the synthesis of adrenocortical hormones, Mitotane slows or stops the growth of tumor cells and improves related symptoms to some extent.What diseases is Mitotan suit···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：241
Mitotane is a drug with a unique mechanism of action that plays an important role in the medical field. In order to help patients better understand Mitotane, the indications relate···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：243
The price of Mitotane has always been a focus of concern for patients and families. Is Mitotane expensive? How much does it cost? This is explained in more detail below.Is Mitotane···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：290
Mitotane is a specific drug for the treatment of adrenocortical carcinoma (ACC), and its price has always been the focus of attention for patients and families. With the changes in···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：285
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：672025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3672024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：612025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：802025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：742025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：902025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：932025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
